Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylation and colorectal cancer.

A M Jubb1, S M Bell, P Quirke

  • 1Academic Unit of Pathology, Algernon Firth Building, University of Leeds, Leeds, LS2 9JT, UK. ugm8amj@leeds.ac.uk

The Journal of Pathology
|September 25, 2001
PubMed
Summary

Epigenetic changes, specifically DNA methylation, play a crucial role in colorectal cancer progression. Aberrant methylation silences tumor suppressor genes, contributing to tumor development alongside genetic mutations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study.

ESMO gastrointestinal oncology·2026
Same author

Corrigendum to "Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population": [Ann Oncol 36 (2025) 520-528].

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

The First Step in Triadic Decision-Making Involving People with Dementia: Determining Who Talks When.

Research on language and social interaction·2024
Same author

Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.

Translational oncology·2024
Same author

The gut microbiota in adults with cystic fibrosis compared to colorectal cancer.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Colorectal adenocarcinoma is a leading cause of cancer death, but genetic mutations alone don't fully explain its development.
  • Epigenetic alterations, particularly DNA methylation, are increasingly recognized as key drivers of tumor progression.

Purpose of the Study:

  • To review epigenetic changes, focusing on DNA methylation, within the colorectal adenoma to adenocarcinoma sequence.
  • To discuss the role of cytosine methylation in gene silencing and its aberrant patterns in aging and cancer.
  • To explore the interplay between epigenetic and genetic lesions in early tumorigenesis and their diagnostic/therapeutic implications.

Main Methods:

  • Literature review and synthesis of current research on epigenetics in colorectal cancer.
  • Analysis of the role of DNA methylation in gene silencing and tumor suppressor gene function.
  • Examination of the relationship between epigenetic modifications and genetic alterations in colorectal tumorigenesis.

Main Results:

  • Aberrant cytosine methylation of CpG islands in promoter regions leads to transcriptional silencing of tumor suppressor genes.
  • Epigenetic and genetic lesions cooperate to establish a CpG island methylator phenotype early in tumor development.
  • Epigenetic alterations are critical determinants of tumor progression in the colorectal adenoma to adenocarcinoma sequence.

Conclusions:

  • Epigenetic changes, especially DNA methylation, are fundamental to colorectal cancer development and progression.
  • Understanding these epigenetic events offers potential for improved molecular pathology, diagnosis, and treatment of colorectal cancer.
  • The interplay between genetic and epigenetic factors is crucial for defining the neoplastic phenotype in colorectal cancer.

Related Experiment Videos